← Back
ORSANMICHELE
December, 08th | 10:30 - 11:30
FREE PAPERS - AMD TREATMENT 2
Add to calendar
Chairs: BOSCIA FRANCESCO, BREAZZANO MARK
December, 08th | 10:30 - 10:33
Standardized multidrug treat and extend protocol for neovascular age-related macular degeneration: a pharmacoeconomic perspective
PAPAYANNIS ALESSANDRO
Add to calendar
Standardized multidrug treat and extend protocol for neovascular age-related macular degeneration: a pharmacoeconomic perspective
PAPAYANNIS ALESSANDRO
Add to calendar
December, 08th | 10:33 - 10:36
Two-years real-life experience of a tertiary center with intravitreal brolucizumab switch for treatment of exudative neovascular age-related macular degeneration
BERETTA FEDERICO
Add to calendar
Two-years real-life experience of a tertiary center with intravitreal brolucizumab switch for treatment of exudative neovascular age-related macular degeneration
BERETTA FEDERICO
Add to calendar
December, 08th | 10:36 - 10:39
Brolucizumab in pigment epithelium detachment secondary to amd
FURINO CLAUDIO
Add to calendar
Brolucizumab in pigment epithelium detachment secondary to amd
FURINO CLAUDIO
Add to calendar
December, 08th | 10:39 - 10:42
56-week results from the talon open-label extension, a phase iiib/iv study of brolucizumab in a treat-and-extend regimen with maximum treatment intervals up to 20 weeks in patients with neovascular age-related macular degeneration
DE SANTI NICOLA
Add to calendar
56-week results from the talon open-label extension, a phase iiib/iv study of brolucizumab in a treat-and-extend regimen with maximum treatment intervals up to 20 weeks in patients with neovascular age-related macular degeneration
DE SANTI NICOLA
Add to calendar
December, 08th | 10:42 - 10:45
Efficacy and durability of faricimab in naïve eyes with neovascular age-related macular degeneration
FORMENTI FEDERICO
Add to calendar
Efficacy and durability of faricimab in naïve eyes with neovascular age-related macular degeneration
FORMENTI FEDERICO
Add to calendar
December, 08th | 10:45 - 10:48
Real-world use of faricimab for patients with neovascular age-related macular degeneration
LA SPINA CARLO
Add to calendar
Real-world use of faricimab for patients with neovascular age-related macular degeneration
LA SPINA CARLO
Add to calendar
December, 08th | 10:48 - 10:51
Pigment epithelial detachment as long-term predictors of functional and anatomical outcomes of intravitreal farcimab injections in naïve patients with neovascular age-related macular
AMBRESIN AUDE
Add to calendar
Pigment epithelial detachment as long-term predictors of functional and anatomical outcomes of intravitreal farcimab injections in naïve patients with neovascular age-related macular
AMBRESIN AUDE
Add to calendar
December, 08th | 10:51 - 10:54
Treat-and-extend 2.0: a modified treatment planning to improve real-life feasibility maintaining close fluids control with faricimab.
ARRIGO ALESSANDRO
Add to calendar
Treat-and-extend 2.0: a modified treatment planning to improve real-life feasibility maintaining close fluids control with faricimab.
ARRIGO ALESSANDRO
Add to calendar
December, 08th | 10:54 - 10:57
Effect of high-dose intravitreal aflibercept in patients with namd: comparison of real-world outcomes with pharmacokinetic model
CARREIRA PEDRO
Add to calendar
Effect of high-dose intravitreal aflibercept in patients with namd: comparison of real-world outcomes with pharmacokinetic model
CARREIRA PEDRO
Add to calendar
December, 08th | 10:57 - 11:00
Real-world effectiveness and safety of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema: design of the spectrum study
BAILEY CLARE
Add to calendar
Real-world effectiveness and safety of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema: design of the spectrum study
BAILEY CLARE
Add to calendar
December, 08th | 11:00 - 11:03
Vision and anatomical outcomes following a loading dose of four intravitreal aflibercept or faricimab in naïve exudative age-related macular degeneration.
DE SALVO GABRIELLA
Add to calendar
Vision and anatomical outcomes following a loading dose of four intravitreal aflibercept or faricimab in naïve exudative age-related macular degeneration.
DE SALVO GABRIELLA
Add to calendar
December, 08th | 11:03 - 11:06
Subretinal injection of recombinant tissue plasminogen activator and gas tamponade to displace acute submacular haemorrhages secondary to age-related macular degeneration
MAGLIOZZI PATRIZIO
Add to calendar
Subretinal injection of recombinant tissue plasminogen activator and gas tamponade to displace acute submacular haemorrhages secondary to age-related macular degeneration
MAGLIOZZI PATRIZIO
Add to calendar
December, 08th | 11:06 - 11:09
High resolution optical coherence tomography reveals details of regeneration after selective retina therapy
DYSLI CHANTAL
Add to calendar
High resolution optical coherence tomography reveals details of regeneration after selective retina therapy
DYSLI CHANTAL
Add to calendar
December, 08th | 11:09 - 11:12
EYP-1901 (vorolanib intravitreal insert) versus aflibercept for previously-treated wet age-related macular degeneration: davio 2 phase 2 1-year results
LOEWENSTEIN ANAT
Add to calendar
EYP-1901 (vorolanib intravitreal insert) versus aflibercept for previously-treated wet age-related macular degeneration: davio 2 phase 2 1-year results
LOEWENSTEIN ANAT
Add to calendar